NCT06468800View on ClinicalTrials.gov

Feasibility and Added Value of the TRACMOTION Device for ESD

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

March 1, 2025

Conditions
Oesophageal Neoplasm
Interventions
DEVICE

TRACMOTION

Patients already scheduled for ESD will undergo an ESD procedure with the aid of the Tracmotion device

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER